SIA FUNDS, EL FONDO QUE CONFÍA EN GRÍFOLS SE POSICIONA EN CONTRA DE LA OPA .: PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer .